This inventor holds 1 USPTO granted patent. Top assignee: The University of Edinburgh. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Charis Georgiou: Innovator in Cyclophilin Modulation
Introduction
Charis Georgiou is a notable inventor based in Edinburgh, GB. He has made significant contributions to the field of pharmaceutical sciences, particularly in the modulation of cyclophilins. His innovative work has the potential to impact the treatment of various disorders.
Latest Patents
Georgiou holds a patent for "Compounds for the modulation of cyclophilins function." This invention relates to compounds of formula (I) or a pharmaceutically acceptable salt thereof, which are useful as inhibitors of cyclophilins and modulators of cyclophilin-like proteins. The patent outlines the various uses of these compounds in treating different disorders, showcasing the versatility and importance of his research.
Career Highlights
Charis Georgiou is affiliated with The University of Edinburgh, where he continues to advance his research and innovation. His work is characterized by a strong focus on the development of novel compounds that can lead to significant medical advancements.
Collaborations
Georgiou collaborates with esteemed colleagues, including Dahlia Doughty Shenton and Alessio De Simone. These partnerships enhance the scope and impact of his research, fostering a collaborative environment that is essential for scientific progress.
Conclusion
Charis Georgiou's contributions to the field of cyclophilin modulation exemplify the importance of innovation in medical research. His patent and ongoing work at The University of Edinburgh highlight his commitment to advancing healthcare solutions.